Automating Raw Materials Processes in Cell and Gene Therapy Manufacturing Advanced Therapies Connect with CellGenix

Automating Raw Materials Processes in Cell and Gene Therapy Manufacturing

A recorded roundtable discussion from Advanced Therapies connect, lead by CellGenix

Automation is crucial for commercialisation, but how are you approaching automation of raw material processes?

This roundtable discussion focused on which raw material characteristics would enable you to automate your processes, the biggest raw material challenges facing advanced therapy developers and manufacturers and how we, as an industry, can accomplish global standardisation.

The interim results of a recent survey were also discussed during the roundtable. It's not too late to share your insights and take the survey here.

This roundtable took place during Phacilitate's virtual meeting, Advanced Therapies Connect and was lead by Evelien Nijssen at CellGenix.


BACK TO MEMBER ZONE